Achieve Life Sciences Inc (STU:SP4P)
€ 5.35 -0.20 (-3.6%) Market Cap: 550.80 Mil Enterprise Value: 538.22 Mil PE Ratio: 0 PB Ratio: 30.40 GF Score: 32/100

Q3 2025 Achieve Life Sciences Inc Earnings Call Transcript

Nov 6, 2025 / 01:30 PM GMT
Release Date Price: €4.02 (-5.53%)

Key Points

Positve
  • Achieve Life Sciences Inc (ACHV) received a Commissioner's National Priority voucher from the FDA for the e-cigarette or vaping indication, expediting the NDA review timeline.
  • The FDA accepted the new drug application for cytocinnoline for smoking cessation, setting a PDUFA date of June 20, 2026.
  • Phase 3 clinical trials showed higher quit rates for smokers with COPD using cytocinnoline compared to placebo.
  • Achieve Life Sciences Inc (ACHV) is leveraging AI and machine learning for a data-driven commercialization strategy, optimizing campaigns and enhancing engagement.
  • The company has a strong balance sheet with $48.1 million in cash and marketable securities, expected to fund operations into the second half of 2026.
Negative
  • Achieve Life Sciences Inc (ACHV) will need to raise additional capital to complete the vaping study.
  • The cash runway does not cover the funding for the vaping study, indicating potential financial constraints.
  • The company faces competition from Pfizer's reintroduction of Chantix, despite the presence of generics in the market.
  • The vaping study protocol indicates a higher nicotine dependence in vapers, which may present challenges in treatment efficacy.
  • The company is targeting a younger demographic for vaping cessation, which may require different marketing strategies and resources.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ACHV.OQ - Achieve Life Sciences Inc
Q3 2025 Achieve Life Sciences Inc Earnings Call
Nov 06, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Achieve Life Sciences 3rd quarter 2025 earnings conference call and webcast. At this time, all participants are in a listen-only mode.

A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.

I would now like to turn the call over to Nicole Jones, Chiefs Vice President, Strategic Communications and Stakeholder Relations.

Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good morning, everyone, and thank you for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot